Luna Zaru

1.9k total citations
23 papers, 475 citations indexed

About

Luna Zaru is a scholar working on Epidemiology, Hepatology and Oncology. According to data from OpenAlex, Luna Zaru has authored 23 papers receiving a total of 475 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 7 papers in Hepatology and 5 papers in Oncology. Recurrent topics in Luna Zaru's work include Liver Disease Diagnosis and Treatment (11 papers), Liver Diseases and Immunity (4 papers) and Liver Disease and Transplantation (3 papers). Luna Zaru is often cited by papers focused on Liver Disease Diagnosis and Treatment (11 papers), Liver Diseases and Immunity (4 papers) and Liver Disease and Transplantation (3 papers). Luna Zaru collaborates with scholars based in United States, Jordan and France. Luna Zaru's co-authors include Ghadeer A. R. Y. Suaifan, Mayadah B. Shehadeh, Rula M. Darwish, Mayyada Wazaify, Dieter Felsenberg, Jorge B. Cannata‐Andía, Silvano Adami, Mohammed Milhem, Arthur C. Santora and Richard A. Petruschke and has published in prestigious journals such as Gastroenterology, Hepatology and Critical Care Medicine.

In The Last Decade

Luna Zaru

22 papers receiving 459 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luna Zaru United States 9 194 151 94 73 72 23 475
Hyun Soon Sohn South Korea 14 29 0.1× 91 0.6× 59 0.6× 5 0.1× 36 0.5× 59 508
Brice Amadéo France 12 212 1.1× 113 0.7× 56 0.6× 65 0.9× 28 450
Aristofanis Gikas Greece 14 120 0.6× 164 1.1× 49 0.5× 36 0.5× 22 592
Agata Schlesinger Israel 8 29 0.1× 78 0.5× 104 1.1× 38 0.5× 5 0.1× 11 326
Matthew Rawlins Australia 9 71 0.4× 65 0.4× 11 0.1× 18 0.2× 3 0.0× 42 323
Anna Sick-Samuels United States 13 85 0.4× 143 0.9× 27 0.3× 48 0.7× 40 530
Johanita R. Burger South Africa 10 196 1.0× 88 0.6× 18 0.2× 40 0.5× 40 358
Kevin G. Moores United States 13 8 0.0× 41 0.3× 53 0.6× 12 0.2× 26 0.4× 19 423
María Victoria Martínez Calvo Spain 14 48 0.2× 144 1.0× 72 0.8× 52 0.7× 44 620
Hoan Linh Banh Canada 11 12 0.1× 90 0.6× 18 0.2× 30 0.4× 6 0.1× 40 378

Countries citing papers authored by Luna Zaru

Since Specialization
Citations

This map shows the geographic impact of Luna Zaru's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luna Zaru with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luna Zaru more than expected).

Fields of papers citing papers by Luna Zaru

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luna Zaru. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luna Zaru. The network helps show where Luna Zaru may publish in the future.

Co-authorship network of co-authors of Luna Zaru

This figure shows the co-authorship network connecting the top 25 collaborators of Luna Zaru. A scholar is included among the top collaborators of Luna Zaru based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luna Zaru. Luna Zaru is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alkhouri, Naim, Jeffrey E. Edwards, Fred Poordad, et al.. (2024). Safety, pharmacokinetics and pharmacodynamics of obeticholic acid in subjects with fibrosis or cirrhosis from NASH. Liver International. 44(4). 966–978. 10 indexed citations
2.
Carr, Rotonya M., Yun Li, Lillian Chau, et al.. (2023). An integrated analysis of fecal microbiome and metabolomic features distinguish non-cirrhotic NASH from healthy control populations. Hepatology. 78(6). 1843–1857. 16 indexed citations
3.
Loomba, Rohit, Quentin M. Anstee, Stephen A. Harrison, et al.. (2021). P213 Obeticholic acid improves hepatic fibroinflammation assessed by multiparametric MRI: interim results of the regenerate trial. A153.1–A153. 1 indexed citations
4.
Sanyal, A., Vlad Ratziu, Rohit Loomba, et al.. (2020). OC.05.5 OBETICHOLIC ACID TREATMENT IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS: A SECONDARY ANALYSIS OF THE REGENERATE STUDY ACROSS FIBROSIS STAGES. Digestive and Liver Disease. 52. S19–S20. 1 indexed citations
5.
Loomba, Rohit, Quentin M. Anstee, Stephen A. Harrison, et al.. (2020). Tu1665 OBETICHOLIC ACID IMPROVES HEPATIC FIBROINFLAMMATION AS ASSESSED BY MULTIPARAMETRIC MRI: INTERIM RESULTS OF THE REGENERATE TRIAL. Gastroenterology. 158(6). S–1443. 1 indexed citations
6.
Sanyal, Arun J., Vlad Ratziu, Rohit Loomba, et al.. (2020). Obeticholic Acid Treatment in Patients with Non-Alcoholic Steatohepatitis: A Secondary Analysis of the Regenerate Study Across Fibrosis Stages. Digestive and Liver Disease. 52. e46–e47. 3 indexed citations
7.
8.
Geier, Andreas, Vlad Ratziu, Rohit Loomba, et al.. (2020). Obeticholic acid treatment in patients with non-alcoholic steatohepatitis: a secondary analysis of the REGENERATE study across fibrosis stages. Zeitschrift für Gastroenterologie.
9.
Loomba, Rohit, Quentin M. Anstee, Stephen A. Harrison, et al.. (2020). Obeticholic acid improves hepatic fibroinflammation as assessed by multiparametric magnetic resonance imaging: interim results of the regenerate trial. Journal of Hepatology. 73. S432–S433. 2 indexed citations
10.
Younossi, Zobair M., Vlad Ratziu, Rohit Loomba, et al.. (2019). OTU-14 Positive results from REGENERATE: a phase 3 international, randomized, placebo-controlled study evaluating obeticholic acid treatment for NASH. A108.2–A108. 9 indexed citations
11.
Cotton, Mark F., et al.. (2017). Safety and Efficacy of Atazanavir Powder and Ritonavir in HIV-1-Infected Infants and Children From 3 Months to <11 Years of Age. The Pediatric Infectious Disease Journal. 37(6). e149–e156. 2 indexed citations
12.
Al‐Omari, Amal, et al.. (2013). Perception and attitude of Jordanian physicians towards complementary and alternative medicine (CAM) use in oncology. Complementary Therapies in Clinical Practice. 19(2). 70–76. 19 indexed citations
13.
Shehadeh, Mayadah B., et al.. (2011). Knowledge, attitudes and behavior regarding antibiotics use and misuse among adults in the community of Jordan. A pilot study. Saudi Pharmaceutical Journal. 20(2). 125–133. 221 indexed citations
14.
Rihani, Rawad, et al.. (2011). Outcome of childhood acute lymphoblastic leukemia in Jordan. Pediatric Blood & Cancer. 57(3). 385–391. 31 indexed citations
15.
Hawari, Feras, et al.. (2009). The effect of implementing high-intensity intensive care unit staffing model on outcome of critically ill oncology patients*. Critical Care Medicine. 37(6). 1967–1971. 35 indexed citations
16.
Milhem, Mohammed, et al.. (2008). A positive antinuclear antibody test predicts for a poor response to initial steroid therapy in adults with idiopathic thrombocytopenic purpura. Annals of Hematology. 87(6). 459–462. 21 indexed citations
17.
Tuffaha, Haitham, Imad Treish, & Luna Zaru. (2008). The use and effectiveness of granulocyte colony-stimulating factor in primary prophylaxis for febrile neutropenia in the outpatient setting. Journal of Oncology Pharmacy Practice. 14(3). 131–138. 5 indexed citations
18.
Bergman, Arthur, Amy O. Johnson‐Levonas, Joanne Burke, et al.. (2005). Assessment of pharmacokinetic interactions between ezetimibe and cyclosporine. Clinical Pharmacology & Therapeutics. 77(2). P75–P75. 6 indexed citations
19.
Hosking, D., S. Adámi, Dieter Felsenberg, et al.. (2003). Once weekly alendronate produces a greater increase in bone mineral density than daily risedronate. Open Repository and Bibliography (University of Liège). 1 indexed citations
20.
Hosking, David, Silvano Adami, Dieter Felsenberg, et al.. (2003). Comparison of change in bone resorption and bone mineral density with once-weekly alendronate and daily risedronate: a randomised, placebo-controlled study. Current Medical Research and Opinion. 19(5). 383–394. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hyun Soon Sohn Breakdown of academic impact, for papers by Brice Amadéo Breakdown of academic impact, for papers by Aristofanis Gikas Breakdown of academic impact, for papers by Agata Schlesinger Breakdown of academic impact, for papers by Matthew Rawlins Breakdown of academic impact, for papers by Anna Sick-Samuels Breakdown of academic impact, for papers by Johanita R. Burger Breakdown of academic impact, for papers by Kevin G. Moores Breakdown of academic impact, for papers by María Victoria Martínez Calvo Breakdown of academic impact, for papers by Hoan Linh Banh
Rankless by CCL
2026